Drug recall · March 20, 2019
Gentamicin Sulfate Ophthalmic Solution recall
Why: Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gentamicin Sulfate Ophthalmic Solution, USP, 0.3%, 5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-283-10.
- Lots / codes
Lot 7B71A, Exp 01/2020
- Quantity
- 51,456 bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- February 22, 2019 · Voluntary: Firm initiated
- Classified
- March 11, 2019
- Reported
- March 20, 2019
- Ended
- August 9, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gentamicin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.